E. Valls Pascual

Should We Redefine Treatment Targets in Rheumatoid Arthritis? Low Disease Activity Is Sufficiently Strict for Patients Who Are Anticitrullinated Protein Antibody-negative

P. V. van Riel, J. Fransen, A. D. den Broeder, 2013, The Journal of Rheumatology.

Central serous chorioretinopathy and systemic corticosteroids in rheumatic diseases: report of three cases

L. Martínez-Costa, E. Valls Pascual, F. Santander, 2015, BMC Musculoskeletal Disorders.

Ophthalmic and Neuro-ophthalmic Manifestations of Coronavirus Disease 2019 (COVID-19)

E. Valls Pascual, Lucía Martínez Costa, A. Ortiz-Seller, 2020, Ocular immunology and inflammation.

Syphilitic Interstitial Keratitis in a Patient Diagnosed With Sjögren's Syndrome.

L. Martínez-Costa, E. Valls Pascual, Walid Baali, 2017, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

Clinical characteristics, treatment and ocular complications of HLA-B27-related anterior uveitis and HLA-B27-non related anterior uveitis.

E. Vicens Bernabeu, L. Martínez-Costa, E. Valls Pascual, 2016, Reumatologia clinica.

The effect of biologic therapy different from infliximab or adalimumab in patients with refractory uveitis due to Behçet's disease: results of a multicentre open-label study.

M. González-Gay, M. V. Hernández, M. Mesquida, 2016, Clinical and experimental rheumatology.

Anti-TNF-α therapy in patients with refractory uveitis due to Behçet's disease: a 1-year follow-up study of 124 patients.

F. Romero-Bueno, S. Muñoz Fernández, E. Pato, 2014, Rheumatology.

Anti-IL6-Receptor Tocilizumab in Refractory and Noninfectious Uveitic Cystoid Macular Edema: Multicenter Study of 25 Patients.

M. González-Gay, G. Díaz-Cordovés, M. V. Hernández, 2019, American journal of ophthalmology.

Snyder-Robinson syndrome: differential diagnosis of osteogenesis imperfecta

Á. Martínez-Ferrer, I. Vazquez Gomez, E. Valls Pascual, 2021, Osteoporosis International.

Tocilizumab in Behçet's disease with refractory ocular and/or neurological involvement: response according to different clinical phenotypes.

M. González-Gay, J. Nolla, R. Blanco, 2021, Clinical and Experimental Rheumatology.